Concurrent Validity of Two Observer-Rated Alexithymia Measures
Concurrent Validity of Two Observer-Rated Alexithymia Measures
Concurrent Validity of Two Observer-Rated Alexithymia Measures
Alexithymia Measures
MARK G. HAVILAND, PH.D., W. LOUISE WARREN, PH.D.
MATT L. RIGGS, PH.D., STEPHEN R. NITCH, PH.D.
The purposes of the present study were to evaluate 1) the correspondence between two observerrated alexithymia measures, the Observer Alexithymia Scale and the modied Beth Israel Hospital Psychosomatic Questionnaire (BIQ) and 2) the psychometric properties of both instruments.
Clinical and counseling psychologists (N131) used the two instruments to rate outpatients with
various psychiatric diagnoses. Correspondence was excellent; the correlation between the two
scales was 0.69. Moreover, Observer Alexithymia Scale and modied BIQ scores are reliable (total and subscale alphas were within acceptable ranges), and both theoretical structures were
conrmed. Both instruments can be recommended for alexithymia studies requiring observer
ratings.
(Psychosomatics 2002; 43:472477)
472
Haviland et al.
measure), correspondence between the Observer Alexithymia Scale and other observer-rated alexithymia scales
has not been examined. Thus, the primary purpose of the
present study was to evaluate correspondence between the
Observer Alexithymia Scale and the modied BIQ. Our
secondary purpose was to evaluate the psychometric
properties of both measures.
METHOD
Survey
We surveyed by mail a random sample of 1,200 doctoral-level clinical and counseling psychologists, all of
whom were American Psychological Association members
providing patient care. Psychologists were asked to think
of a patient (18 years or older) whom they knew very well
and to rate the patient on the Observer Alexithymia Scale,
the modied BIQ, and two emotional responsivity items.
Our rst preference was for each to choose a patient with
a DSM-IV axis I diagnosis of substance dependence or
abuse, panic disorder, posttraumatic stress disorder, somatoform disorder, or eating disorder. Our second preference was for them to choose a patient with acute stress,
generalized anxiety disorder, major depressive disorder, or
dysthymic disorder. We asked them not to choose patients
with delirium or dementia, bipolar disorder, or schizophrenia (because the data would be difcult to interpret) or with
an axis II diagnosis of schizoid or antisocial personality
disorder (disorders sharing features with, but distinct from,
alexithymia). Alexithymia is associated with our rst
preference disorders and not necessarily with the second
preference disorders. Our goal was to have a good range
of alexithymia severity in the nal sample.
The psychologists also were asked to provide information about themselves (sex and age) and their target patients (sex, age, race/ethnicity, educational level, and psychiatric diagnoses).
Instruments
The Observer Alexithymia Scale is a 33-item inventory, and each item is rated on a 4-point scale (0never
or not at all like the person; 1sometimes or a little like
the person; 2usually or very much like the person; and
3all of the time or completely like the person). Total
scores can thus range from 0 to 99. The scale structure has
ve factors: distant (poor interpersonal skills and relationships), uninsightful (poor stress tolerance, insight, and selfPsychosomatics 43:6, November-December 2002
individuals with severe/trait alexithymia, these gures increased our condence that such was the case.
RESULTS
Concurrent Validity
Response Rate
Descriptive Statistics
Mean total and subscale scores (for all subjects and by
sex) on the Observer Alexithymia Scale and modied BIQ
are shown in Table 1. The differences between women and
men were unremarkable. For example, men had slightly
higher total scores than women on the Observer Alexithymia Scale (effect size, i.e., the mean difference divided by
the pooled standard deviation19: d0.10). The largest sex
differences were on the distant and somatizing subscales
(d0.50 and 0.38, respectively, with men scoring higher
than women on the distant subscale and women scoring
higher than men on the somatizing subscale). Men had
higher total scores than women on the modied BIQ and
higher scores on the affect awareness and operatory thinking subscales. The effect sizes, however, were in the smallto-medium range (d0.52, 0.37, and 0.57, respectively).
Psychometric Evaluations
For the Observer Alexithymia Scale, coefcient alpha
for the total scale was 0.90. Subscale alphas were as follows:
distant0.87, uninsightful0.78, somatizing0.89, humorless0.87, rigid0.71. For the modied BIQ, coefcient alpha for the total scale was 0.85. Alphas for the affect
awareness and operatory thinking subscales were 0.82 and
0.73, respectively.
Consistent with previous conrmatory factor analysis
results for the Observer Alexithymia Scale,6,7 the largest
sources of model mist in the initial run were correlated
Psychosomatics 43:6, November-December 2002
Haviland et al.
errors at the parcel level. Two error covariances were
added,20 and the relaxed model was rerun. The results are
presented in Figure 1. Parcels are represented by the boxes
labeled P11, P12, and so forth. The rst-order factors are
distant, uninsightful, somatizing, humorless, and rigid. The
second-order factor is alexithymia. The omnibus t as assessed by the comparative t index was good (0.935). A
goodness-of-t index of 0.892 and a root mean square error
of approximation of 0.096 also suggested good ts. Although the chi-square statistic was signicant (v2104.70,
df48, N131, p0.001), it was just over the desired 2:1
ratio for chi-square to degrees of freedom. All hypothesized pathways were signicant. The smallest standardized
path coefcient (0.218) was between alexithymia (secondorder factor) and somatizing (rst-order factor).
The largest sources of model mist in the preliminary
analyses of the modied BIQ model were correlated error
values between parcels. Two error covariances were
added,20 and the relaxed model was rerun. The nal model
is shown in Figure 2 (parcels on the left, rst-order factors
[affect awareness and operatory thinking] in the middle,
and the second-order factor [alexithymia] on the right). The
model represented an excellent t to the data, with a comparative t index of 1.0. The chi-square value was not signicant (v26.06, df6, N131, p0.001), and it was
well below the 2:1 rule. The goodness of t index (0.986)
and the root mean square error of approximation (0.012)
conrmed that both were excellent ts. All hypothesized
pathways were signicant.
DISCUSSION
The Observer Alexithymia Scale appears to be a reliable,
valid measure of alexithymia. Coefcient alphas for the
total scale in clinical and nonclinical samples are approximately 0.90. Moreover, the scale is based on expert conTABLE 1.
Scores on the Observer Alexithymia Scale and Modied Beth Israel Hospital Psychosomatic Questionnaire (BIQ) for Patients
of 131 Clinical and Counseling Psychologists Participating in a Random Survey
All Patients (N131)
Measure
Observer Alexithymia Scale (33 items)
Distant (10 items)
Uninsightful (8 items)
Somatizing (5 items)
Humorless (5 items)
Rigid (5 items)
Modied BIQ (12 items)
Affect awareness (6 items)
Operatory thinking (6 items)
Women (N91)
Men (N40)
Mean
SD
Mean
SD
Mean
SD
48.9
15.0
13.5
8.0
6.2
6.3
46.9
23.2
23.8
14.9
5.8
4.4
4.6
3.3
3.3
13.1
7.7
6.8
48.5
14.1
13.6
8.5
5.9
6.3
44.9
22.3
22.6
15.1
5.7
4.4
4.5
3.2
3.4
12.8
7.5
6.5
50.0
17.1
13.1
6.8
6.9
6.2
51.6
25.1
26.5
14.8
5.7
4.5
4.6
3.4
3.3
12.7
7.8
6.8
475
476
0.02
0.22
0.16
0.13
0.16
0.12
0.14
0.34
0.34
0.45
0.47
0.56
0.26
0.50
0.44
0.54
0.06
0.62
0.46
0.71
0.79
0.48
0.51
0.40
0.81
0.79
0.47
0.67
0.72
0.69
0.75
0.48
0.52
0.45
Humorless
Consciously experiences emotional feelings that are consistent with the external situations.
Expresses emotions that are consistent with the external situations.
Somatizing
Uninsightful
Total
Measure
Affect Awareness
0.63
0.48
0.38
Total
0.92
0.89
0.43
0.36
0.557
0.48
0.51
0.34
0.34
0.31
Rigid
0.29
0.27
Operatory Thinking
0.56
Item 1a
Item 2b
Emotional
Responsivity Item
Score
TABLE 2. Correlations Among Scores on the Observer Alexithymia Scale, Modied Beth Israel Hospital Psychosomatic Questionnaire (BIQ), and Emotional Responsivity Items
for Patients of 131 Clinical and Counseling Psychologists Participating in a Random Survey
0.587
FIGURE 2.
0.433
P11
0.257
P12
0.642
P13
0.681
P21
0.607
P22
0.692
P23
0.105
P31
P32
P41
0.280
P42
0.549
P51
0.681
P52
0.721
P11
0.495
P12
0.670
P13
0.760
P21
0.873
P22
0.846
P23
0.901
0.966
0.732
0.795
0.722
0.994
0.831
0.810
0.960
0.836
0.591
Distant
Uninsightful
0.976
Somatizing
Humorless
Rigid
0.693
0.221
0.869
Affect
Awareness
0.650
0.197
0.488
Operatory
Thinking
0.806
0.767
0.665
0.747
Alexithymia
0.218
0.697
0.717
0.659
0.752
0.733
0.975
0.742
Alexithymia
0.980
0.533
Haviland et al.
short of the preferred N200 (we were within the 5-to-1
subject-to-item ratio in the case of the modied BIQ but
outside it with the Observer Alexithymia Scale).23
Also, the same psychologist rated each patient. Moreover, we have yet to establish interrater reliability. A preferred use of the Observer Alexithymia Scale, however, is
for a researcher, for example, to ask several of a subjects
acquaintances or friends to rate the subject, to form a composite rating, and to compare the (more reliable) composite
rating with other direct and indirect alexithymia measures.
At this juncture, it seems reasonable to conclude that
the Observer Alexithymia Scale will be helpful in alexithymia studies that call for an observer-rated measure.
It is brief and can be completed by professionals or rela-
tives and acquaintances. Equally reasonable is to recommend the modied BIQ as an observer-rated measure
(particularly when professional raters are available to rate
patients after a semistructured interview24), for it now has
shown relatively good correspondence with the 20-item
Toronto Alexithymia Scale5,25 and the Observer Alexithymia Scale.
Supported, in part, by the Department of the Army
(Cooperative Agreement Number DAMD17-97-2-7016).
The content of this paper does not necessarily reect the
position or the policy of the government or the National
Medical Technology Testbed. No ofcial endorsement
should be inferred.
References
477